Abstract
The Pel exopolysaccharide is one of the most mechanistically conserved and phylogenetically diverse bacterial biofilm matrix determinants. Pel is a major contributor to the structural integrity of Pseudomonas aeruginosa biofilms, and its biosynthesis is regulated by the binding of cyclic-3′,5′-dimeric guanosine monophosphate (c-di-GMP) to the PelD receptor. c-di-GMP is synthesized from two molecules of guanosine triphosphate (GTP) by diguanylate cyclases with GGDEF domains and degraded by phosphodiesterases with EAL or HD-GYP domains. As the P. aeruginosa genome encodes 43 c-di-GMP metabolic enzymes, one way signaling specificity can be achieved is through direct interaction between specific enzyme-receptor pairs. Here, we show that the inner membrane hybrid GGDEF-EAL enzyme, BifA, directly interacts with PelD via its cytoplasmic HAMP, GGDEF, and EAL domains. Despite having no catalytic function, the degenerate active site motif of the BifA GGDEF domain (GGDQF) has retained the ability to bind GTP with micromolar affinity. Mutations that abolish GTP binding result in increased biofilm formation but stable global c-di-GMP levels. Our data suggest that BifA forms a dimer in solution and that GTP binding induces conformational changes in dimeric BifA that enhance the BifA-PelD interaction and stimulate its phosphodiesterase activity, thus reducing c-di-GMP levels and downregulating Pel biosynthesis. Structural comparisons between the dimeric AlphaFold2 model of BifA and the structures of other hybrid GGDEF-EAL proteins suggest that the regulation of BifA by GTP may occur through a novel mechanism.
| Original language | English |
|---|---|
| Pages (from-to) | e0033123 |
| Journal | Journal of Bacteriology |
| Volume | 206 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2024 |
Funding
This work was supported in part by grants from the Canadian Institutes of Health to P.L.H. (FDN154327) and the National Institute of Health to G.A.O. (R37/AI83256). P.L.H. was the recipient of a Tier 1 Canada Research Chair (2006–2020). This work was supported by the Canada 150 Research Chairs program (C150-2017-00015), the Canada Foundation for Innovation (CFI-37589), the National Institutes of Health (1R01GM120600), and the Natural Sciences and Engineering Research Council of Canada (DG-RGPIN-2019– 05637) to B.D. UltraScan supercomputer calculations were supported through an NSF/ XSEDE grant (TG-MCB070039N) and a University of Texas grant (TG457201) to B.D. This research has been supported by graduate student scholarships from the Province of Ontario (J.C.V.L.), The Hospital for Sick Children Foundation Student Scholarship Program (J.C.V.L.), Cystic Fibrosis Canada (G.B.W.), the Natural Science and Engineering Research Council of Canada (J.V.L., G.B.W., and A.H.). L.O. was supported by a Cystic Fibrosis Foundation Postdoctoral Fellowship (ONEAL20F0).
| Funders | Funder number |
|---|---|
| TG-MCB070039N | |
| R37/AI83256, 1R01GM120600 | |
| ONEAL20F0 | |
| University of Texas at Austin | TG457201 |
| Government of Ontario | |
| Canadian Institutes of Health Research | FDN154327 |
| DG-RGPIN-2019– 05637 | |
| Canada Foundation for Innovation | CFI-37589 |
| C150-2017-00015 |
Keywords
- GTP
- Pseudomonas
- c-di-GMP
- phosphodiesterase
- regulation
- Cyclic GMP/metabolism
- Pseudomonas aeruginosa/genetics
- Phosphoric Diester Hydrolases/metabolism
- Bacterial Proteins/metabolism
- Biofilms
- Escherichia coli Proteins/metabolism
- Guanosine Triphosphate/metabolism
- Gene Expression Regulation, Bacterial